← All Sponsors
SPONSOR

BioMarin Pharmaceutical

Total Trials
2
Recruiting
2
Phases
Phase 2
Conditions studied: Phenylketonuria (PKU)Hypochondroplasia
NCT05813678
Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

Phenylketonuria (PKU)
United States, Germany, Italy View Trial →
NCT07126262 Phase 2
Recruiting

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

Hypochondroplasia
United States, Australia, France View Trial →